[vc_row][vc_column width="2/3"][vc_column_text css=""]Cancer is devastating at any age. Can you imagine having to experience such an awful disease at the age of three? Around this age, Greyson Banovich started having excruciating pain in his lower back. Neither he nor his family could understand. Finally, when it...
[vc_row][vc_column][vc_single_image image="51753" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine...
[vc_row][vc_column][vc_single_image image="26978" img_size="full" alignment="center"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Ask any parent about their child fighting cancer, and words like “nightmare” and “helpless” will almost certainly be part of the conversation. Within pediatric cancer medicine, the entire field faces the brutal reality that chemotherapy, surgery, and most other cancer treatments...
[vc_row][vc_column][vc_single_image image="48252" img_size="full" alignment="center"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]A new cancer drug, larotrectinib, has in a very early clinical trial been shown to have a 93% (14/15) effectiveness rate for pediatric cancers; that is to say, for not just one cancer, but many. Hailed by the U.S. Food and Drug...
September is Childhood Cancer Awareness Month. As childhood cancer rates have been rising slightly for the past few decades and continue to affect the lives of children and their families worldwide, it’s important to understand it....
Search NFCR
Popular searches
